The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and toxicity of sunitinib in renal insufficiency patients with metastatic renal cell carcinoma.
Ki Hyang Kim
No relevant relationships to disclose
Sun Young Rha
No relevant relationships to disclose
Ho Young Kim
No relevant relationships to disclose
Hye Ryun Kim
No relevant relationships to disclose
Jong-Mu Sun
No relevant relationships to disclose
Ho Yeong Lim
No relevant relationships to disclose
Hyo Jin Lee
No relevant relationships to disclose
Suee Lee
No relevant relationships to disclose
Woo Kyun Bae
No relevant relationships to disclose